These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7320156)

  • 21. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of endogenous anticoagulant N-sulfated glycosaminoglycans in human plasma from healthy subjects.
    Ruggiero M; Melli M; Parma B; Bianchini P; Vannucchi S
    Pathophysiol Haemost Thromb; 2002; 32(1):44-9. PubMed ID: 12214163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.
    Kalaska B; Sokolowska E; Kaminski K; Szczubialka K; Kramkowski K; Mogielnicki A; Nowakowska M; Buczko W
    Eur J Pharmacol; 2012 Jul; 686(1-3):81-9. PubMed ID: 22579410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
    Gray A; Litinas E; Jeske W; Fareed J; Hoppensteadt D
    Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation of heparin into fractions with different anticoagulant activity by hydrophobic interaction chromatography.
    Ogamo A; Uchiyama H; Nagasawa K
    Biochim Biophys Acta; 1980 Dec; 626(2):477-85. PubMed ID: 7213665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and properties of the anticoagulant principle of Trimeresurus gramineus venom.
    Ouyang C; Yang FY
    Biochim Biophys Acta; 1975 Apr; 386(2):479-92. PubMed ID: 1138881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of raw heparin from dromedary intestine: evaluation of a new source of pharmaceutical heparin.
    Warda M; Gouda EM; Toida T; Chi L; Linhardt RJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2003 Dec; 136(4):357-65. PubMed ID: 15012907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Separation, identification, and interaction of heparin oligosaccharides with granulocyte-colony stimulating factor using capillary electrophoresis and mass spectrometry.
    Liang A; Chao Y; Liu X; Du Y; Wang K; Qian S; Lin B
    Electrophoresis; 2005 Sep; 26(18):3460-7. PubMed ID: 16100743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of calcium ions on the activated partial thromboplastin time of heparinized plasma.
    Greenberg CS; Adams JP; Mullen PE; Koepke JA
    Am J Clin Pathol; 1986 Oct; 86(4):484-9. PubMed ID: 3766461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of platelet factor 4 to heparin oligosaccharides.
    Denton J; Lane DA; Thunberg L; Slater AM; Lindahl U
    Biochem J; 1983 Feb; 209(2):455-60. PubMed ID: 6847629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Partial purification of tissue thromboplastin by the gel filtration method and its use for reproducing the generalized decompensated thrombinogenesis syndrome].
    Magerovskiĭ IuV; Monastyrskiĭ VA; Gaĭda AV; Birka II; Voroniak MI
    Vopr Med Khim; 1988; 34(3):34-9. PubMed ID: 3420807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.
    Takemoto CM; Streiff MB; Shermock KM; Kraus PS; Chen J; Jani J; Kickler T
    Am J Clin Pathol; 2013 Apr; 139(4):450-6. PubMed ID: 23525615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
    Han F; Yao W; Yang X; Liu X; Gao X
    Int J Biol Macromol; 2005 Sep; 36(4):201-7. PubMed ID: 16102810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord.
    Reutelingsperger CP; Hornstra G; Hemker HC
    Eur J Biochem; 1985 Sep; 151(3):625-9. PubMed ID: 3896792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of heparin from human mastocytoma tissue.
    Thunberg L; Höök M; Lindahl U; Abildgaard U; Langholm R
    Thromb Haemost; 1980 Dec; 44(3):125-9. PubMed ID: 6781095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and properties of guinea pig antithrombin III.
    Heck L; Rosenberg R; Remold H
    Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metachromatic activity of heparin and heparin fragments.
    Grant AC; Linhardt RJ; Fitzgerald GL; Park JJ; Langer R
    Anal Biochem; 1984 Feb; 137(1):25-32. PubMed ID: 6203432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From heparin to heparin fractions and derivatives.
    Coyne E
    Semin Thromb Hemost; 1985 Jan; 11(1):10-2. PubMed ID: 3883496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.